Press

Pioneering a Human-Centric Approach to Managing Cardiac Patients

New York, NY 11-8-2023 – Access Telehealth, a trailblazer in redefining healthcare solutions, proudly announces its strategic partnership with VDO Cardiology, a virtual first, innovation led and quality focused medical and wellness practice. With a strong emphasis on the "human touch," Access Telehealth is revolutionizing patient care by integrating innovative digital health technology with personalized patient engagement.

Enriching Lives through Technology and Connection

At Access Telehealth, we're on a dual mission: to connect patients and providers through remote patient monitoring, fostering connections that not only drive better outcomes but also propel healthcare organizations towards financial success. By nurturing these connections, we're not just reducing healthcare costs; we're amplifying revenue streams, forging a powerful synergy where patient well-being and organizational prosperity thrive hand in hand.

Human Touch, Technological Excellence the Access Telehealth Difference

Unlike traditional RPM services, Access Telehealth recognizes that technology alone cannot drive optimal patient outcomes. The company's clinical team is committed to forging genuine patient relationships and rapport, resulting in heightened patient engagement and a renewed commitment to their health journey. This proven approach yields remarkable outcomes, translating into healthier patients and enhanced financial viability for healthcare organizations.

Customized Solutions for Diverse Goals

VDO Cardiology, is a leader in Cardiology and Cardiac Electrophysiology and a suite of promising ancillary services including vein treatments in the Metro New York and Tri-state area delivering exceptional care. Dr. Jay Doshi, MD, an award-winning lead physician and Founder of VDO Cardiology is affiliated with major ACOs, hospital systems and academic research institutions driving the development of modernized less invasive treatment protocols with high impact clinical outcomes. Through established and growing community relationships, VDO Cardiology improves patient access over a wider region and has a suite of remotely managed care, rehab and monitoring services catered to patient needs. Dr. Jay V. Doshi, highly recommends Access Telehealth to enhance the level of care for patients who need overall management of their cardiac disease.

VDO Cardiology understands the importance of staying connected with the patients they care for and providing optimized, continuous care. Remote Patient Monitoring makes that connection simple for the patients. 

Remote Patient Monitoring provides VDO cardiology patients with the support they need to stay on track with their care plan. Patients can achieve better outcomes and medication management by regularly transmitting physiologic data with easy-to-use connected devices. When readings are out of the expected range, the VDO Cardiology team can intervene quickly.

Remote Patient Monitoring ensures that patients are not just monitored but are also understood and cared for, providing valuable insights between regular medical visits. This continuous connection can be invaluable, especially for patients who require consistent medical attention, offering them a sense of security and well-being.

Access Telehealth remains dedicated to pioneering innovative solutions that transcend the status quo by offering disease specific programs in partnership with organizations such as VDO Cardiology.  These alliances are the catalysts for transformative change within the healthcare landscape by fostering robust patient-provider relationships and delivering unprecedented patient care.

About VDO Cardiology:

VDO Cardiology, an independent practice, works in association with Middletown Medical in Orange County, NY and Heart Rhythm Associates in New York, NY in providing cardiovascular and electrophysiology care. These relationships give our patients access to state-of-the-art imaging and cutting-edge therapeutic technologies.

www.vdocardiology.com

Address: 325 S Highland Ave, Ste 103, Briarcliff Manor, NY, 10510

Phone: (914) 266-2280

About Access Telehealth

Access Telehealth stands at the forefront of healthcare evolution, seamlessly merging technology, and human connection in the realm of Remote Patient Monitoring. As a digital health innovator, Access Telehealth is committed to delivering innovative connected care solutions for management of people living with chronic disease.  Focusing on virtual care initiatives, the Access Telehealth clinical team delivers patient-centric remote monitoring services to support disease specific chronic care programs for health systems, payors and providers, to enhance care delivery.

www.accessrpm.com

Highlights:

• Access Telehealth and wheezo^® have been selected for an RPM pilot program to help manage patients suffering from asthma and Chronic Obstructive Pulmonary Disease (COPD) that are cared for by Minnesota Lung Center (MLC).
• Remote Patient Monitoring (RPM) will be delivered through Access Telehealth with the full-service premium model that includes patient engagement using their cloud-based platform, Remotli. This pilot program will be conducted over a few months to ensure seamless integration into MLC’s systems and processes.
• With 9 pulmonologists, 6 mid-levels and an extensive referral network, MLC is one of the largest private pulmonary practices in the Midwest providing care and other related respiratory healthcare services to thousands of patients. MLC also has a robust clinical research program.

Access Telehealth, a digital health company delivering remote care solutions to support patients living with chronic disease, is pleased to announce that they have been chosen by Minnesota Lung Center for a pilot  Remote Patient Monitoring (RPM) program to help manage patients with Chronic Obstructive Pulmonary Disease (COPD) and asthma. The program was secured with our device technology partner Respiri and will provide a full-service RPM solution that includes the Remotli platform, patient engagement and remote monitoring under the supervision of MLC. Initially a pilot program will be conducted with wheezo® over a 3-month period to ensure that the RPM program seamlessly integrates into MLC systems and workflow. 

On the successful completion of the pilot program, that includes integration and successful reimbursement, along with clinical benchmarks, it is anticipated that the Access Telehealth RPM Program and wheezo^®  will be rolled out more broadly for MLC patients.  

Minnesota Lung Center (MLC) was established in 1974 to provide comprehensive specialty care for people with respiratory health needs. MLC is committed to, and renowned for, high quality and compassionate care. They specialize in the treatment of patients with lung diseases and offer patients a wide variety of diagnostic services. MLC services are provided by 9 pulmonary physicians and other dedicated support staff including nurse practitioners, physician assistants, registered nurses, and respiratory therapists.

This is the first time that MLC will provide such a program that focuses on remote respiratory disease monitoring using the novel wheezo^® device and remote patient monitoring services to track and monitor patient physiologic data between clinical visits and after acute care.

COPD in-patient medical services have an average cost of $27,597 and asthma $8,238 per admission. Under the supervision of MLC physicians, Access Telehealth will provide a an RPM program using the innovative wheezo^® technology to enable a cost effective and powerful way to frequently evaluate patient physiologic data and to stay connected with more vulnerable patients to extend care beyond the clinic with a goal of reducing hospitalizations, exacerbations, and other related problems that contribute to escalating healthcare costs in the USA. 

Myra Ameigh, CEO of Access Telehealth said: "COPD and Asthma are among the leading chronic diseases impacting US Healthcare. Our partnership with Respiri allows us to deliver an easy-to-use monitoring device for patients living with chronic respiratory disease and helps to broaden our ability to help patients living with chronic illness. We are extremely impressed with the forward-thinking leadership at MLC and look forward to working with them to build an impactful RPM program for their patients."

Marjan Mikel, CEO of Respiri said, “The Minnesota Lung Center opportunity is a watershed moment for Respiri given they are the first major respiratory healthcare organization to choose our wheezo^® RPM solution. We are, excited about working together with the MLC team to provide even better care for patients and improving their quality of life.”

Dr Jonathan Hovda, MLC Physician, said “Minnesota Lung Center is excited for the opportunity to be working with Respiri on evaluating the wheezo^® device and working with Access Telehealth on RPM logistics, processes, and reimbursement. Using wheezo^® to monitor patients with asthma and COPD and can help identify early changes in symptoms which can help us manage our patients.”

For further information, investors and media please contact:

Lisa Dye

Chief Revenue Officer

Access Telehealth

Phone: (855) 420-1626

Email: ldye@accessrpm.com

About Access Telehealth

Access Telehealth is a digital health company dedicated to delivering innovative connected care solutions for management of people living with chronic disease. The Remotli platform uniquely simplifies remote care delivery with patient engagement and productivity driven dashboard tools to support effective patient care and compliance. Automated care-time tracking, and reimbursement reports makes it easy to boost revenue to support vital chronic disease management programs including Remote Physiologic Monitoring, Remote Therapeutic Monitoring, Transitional Care, Chronic Care Management, Telemedicine and more. Focusing on Remote Physiologic Monitoring and virtual care initiatives, the Access Telehealth clinical team delivers patient-centric remote monitoring services to support disease specific chronic care programs for health systems, payors, and providers, to enhance care delivery. 

About Respiri Limited

Respiri is an e-Health SaaS company supporting respiratory health management. Its world-first technology detects wheeze, a typical symptom of asthma, COPD, and respiratory disease to provide an objective measure of airway limitation. wheezo®, Respiri's innovative technology, comprises an eHealth app combined with a simple, easy to use, handheld device. wheezo® is the first smart device to help improve asthma management by monitoring wheeze and documenting symptoms, signs, triggers, weather conditions and medication use. The asthma management platform also facilitates the sharing of data with caregivers, physicians, and other health care professionals.

Respiri’s mission is to help improve quality of life for hundreds of millions of children and adults around the world and dramatically reduce hospital admissions and the economic burden of asthma. Respiri Limited's operations are based in Melbourne, Australia.

wheezo^® is a registered trademark of Respiri Limited.

Access Telehealth announces a strategic partnership with Respiri Limited (ASX:RSH) to launch a novel Remote Patient Monitoring (RPM) pilot program at Children’s Hospital of Michigan. The program provides an RPM solution for children living with asthma by introducing the use of Respiri’s wheezo® device to facilitate wheeze detection.